Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography | 45 | 2024 | 5045 | 3.660 |
Why?
|
Ventricular Function, Left | 25 | 2020 | 3928 | 2.370 |
Why?
|
Guideline Adherence | 18 | 2020 | 2243 | 2.270 |
Why?
|
Ventricular Remodeling | 20 | 2021 | 1272 | 2.190 |
Why?
|
Athletes | 21 | 2022 | 1162 | 2.180 |
Why?
|
Hypertrophy, Left Ventricular | 11 | 2017 | 855 | 1.960 |
Why?
|
Unnecessary Procedures | 6 | 2017 | 416 | 1.670 |
Why?
|
Heart Ventricles | 16 | 2021 | 3832 | 1.540 |
Why?
|
Physical Endurance | 11 | 2020 | 368 | 1.310 |
Why?
|
Cardiology Service, Hospital | 3 | 2017 | 242 | 1.280 |
Why?
|
Myocardial Contraction | 9 | 2019 | 1515 | 1.150 |
Why?
|
Cardiology | 9 | 2021 | 1702 | 1.010 |
Why?
|
Exercise | 13 | 2020 | 5937 | 1.010 |
Why?
|
Cardiac Imaging Techniques | 3 | 2017 | 280 | 0.950 |
Why?
|
Exercise Tolerance | 6 | 2019 | 841 | 0.920 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2024 | 2136 | 0.840 |
Why?
|
Practice Guidelines as Topic | 11 | 2019 | 7425 | 0.780 |
Why?
|
Utilization Review | 4 | 2016 | 381 | 0.750 |
Why?
|
Cardiovascular Diseases | 13 | 2019 | 15652 | 0.730 |
Why?
|
Electrocardiography | 15 | 2021 | 6404 | 0.730 |
Why?
|
Heart Failure | 17 | 2023 | 11840 | 0.710 |
Why?
|
Adaptation, Physiological | 9 | 2020 | 1308 | 0.680 |
Why?
|
Heart | 9 | 2019 | 4414 | 0.650 |
Why?
|
Competitive Behavior | 2 | 2019 | 77 | 0.640 |
Why?
|
Heart Diseases | 8 | 2019 | 2821 | 0.640 |
Why?
|
Sports | 5 | 2017 | 698 | 0.540 |
Why?
|
Exercise Test | 9 | 2022 | 2180 | 0.530 |
Why?
|
Echocardiography, Stress | 2 | 2016 | 137 | 0.520 |
Why?
|
Hospitalization | 6 | 2023 | 10808 | 0.510 |
Why?
|
Coronary Aneurysm | 1 | 2018 | 233 | 0.500 |
Why?
|
Quality Indicators, Health Care | 3 | 2019 | 1806 | 0.500 |
Why?
|
Physical Fitness | 5 | 2021 | 742 | 0.490 |
Why?
|
Syncope | 1 | 2018 | 429 | 0.490 |
Why?
|
Saphenous Vein | 1 | 2018 | 511 | 0.490 |
Why?
|
Endocardium | 1 | 2016 | 249 | 0.480 |
Why?
|
Football | 3 | 2016 | 504 | 0.450 |
Why?
|
Athletic Performance | 1 | 2015 | 112 | 0.450 |
Why?
|
Clinical Trials as Topic | 3 | 2017 | 8041 | 0.440 |
Why?
|
Coronary Artery Disease | 8 | 2023 | 6544 | 0.440 |
Why?
|
Natriuretic Peptide, Brain | 7 | 2017 | 1736 | 0.430 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2015 | 239 | 0.430 |
Why?
|
Physical Exertion | 2 | 2019 | 665 | 0.420 |
Why?
|
Death, Sudden, Cardiac | 5 | 2016 | 1568 | 0.420 |
Why?
|
Patient Selection | 5 | 2014 | 4255 | 0.420 |
Why?
|
Coronary Vasospasm | 2 | 2023 | 81 | 0.420 |
Why?
|
Mass Screening | 5 | 2012 | 5446 | 0.410 |
Why?
|
Tricuspid Valve | 1 | 2016 | 422 | 0.410 |
Why?
|
Oxygen Consumption | 7 | 2022 | 1870 | 0.410 |
Why?
|
Academic Medical Centers | 5 | 2019 | 2780 | 0.410 |
Why?
|
Stroke Volume | 15 | 2023 | 5596 | 0.400 |
Why?
|
Ambulatory Care | 4 | 2015 | 2778 | 0.390 |
Why?
|
Education, Medical | 2 | 2015 | 1746 | 0.390 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2019 | 1339 | 0.390 |
Why?
|
Endocarditis | 1 | 2016 | 350 | 0.380 |
Why?
|
Pericardium | 1 | 2016 | 679 | 0.380 |
Why?
|
Running | 4 | 2020 | 488 | 0.380 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2013 | 216 | 0.370 |
Why?
|
Quality Improvement | 3 | 2017 | 3853 | 0.360 |
Why?
|
Hand Strength | 2 | 2019 | 462 | 0.360 |
Why?
|
Torsion Abnormality | 1 | 2010 | 92 | 0.340 |
Why?
|
Humans | 117 | 2024 | 765968 | 0.340 |
Why?
|
Exercise Therapy | 2 | 2019 | 937 | 0.340 |
Why?
|
Heat-Shock Response | 1 | 2011 | 179 | 0.330 |
Why?
|
Peptide Fragments | 7 | 2017 | 5125 | 0.330 |
Why?
|
Fibromuscular Dysplasia | 1 | 2009 | 56 | 0.330 |
Why?
|
Coronary Artery Bypass | 2 | 2018 | 2186 | 0.320 |
Why?
|
Echocardiography, Doppler | 8 | 2019 | 899 | 0.320 |
Why?
|
Male | 80 | 2024 | 363698 | 0.320 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 601 | 0.310 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2023 | 669 | 0.310 |
Why?
|
Renal Artery Obstruction | 1 | 2009 | 218 | 0.300 |
Why?
|
Sodium Chloride | 1 | 2010 | 576 | 0.300 |
Why?
|
Crack Cocaine | 1 | 2008 | 33 | 0.300 |
Why?
|
Sports Medicine | 3 | 2017 | 239 | 0.290 |
Why?
|
Fee-for-Service Plans | 1 | 2013 | 716 | 0.290 |
Why?
|
Blood Pressure | 7 | 2019 | 8532 | 0.290 |
Why?
|
Weight Lifting | 3 | 2017 | 130 | 0.280 |
Why?
|
Arteries | 1 | 2012 | 1118 | 0.280 |
Why?
|
Androgens | 4 | 2017 | 1279 | 0.280 |
Why?
|
Attitude of Health Personnel | 3 | 2016 | 3925 | 0.270 |
Why?
|
Brugada Syndrome | 1 | 2008 | 97 | 0.270 |
Why?
|
Advisory Committees | 1 | 2011 | 796 | 0.270 |
Why?
|
Echocardiography, Doppler, Color | 4 | 2012 | 353 | 0.260 |
Why?
|
Ontario | 5 | 2019 | 402 | 0.260 |
Why?
|
Cardiovascular Agents | 1 | 2012 | 851 | 0.260 |
Why?
|
American Heart Association | 1 | 2011 | 1047 | 0.260 |
Why?
|
Prospective Studies | 26 | 2022 | 54802 | 0.250 |
Why?
|
Students | 2 | 2013 | 1734 | 0.250 |
Why?
|
Rest | 1 | 2011 | 942 | 0.250 |
Why?
|
Anabolic Agents | 3 | 2015 | 256 | 0.250 |
Why?
|
Testosterone Congeners | 2 | 2017 | 62 | 0.250 |
Why?
|
Risk Assessment | 12 | 2024 | 24282 | 0.240 |
Why?
|
Heart Rate | 5 | 2019 | 4204 | 0.230 |
Why?
|
Cocaine-Related Disorders | 1 | 2008 | 459 | 0.230 |
Why?
|
Female | 61 | 2024 | 396112 | 0.230 |
Why?
|
Single-Blind Method | 3 | 2017 | 1589 | 0.220 |
Why?
|
Doping in Sports | 2 | 2017 | 63 | 0.220 |
Why?
|
Longitudinal Studies | 12 | 2020 | 14751 | 0.210 |
Why?
|
Health Resources | 2 | 2019 | 949 | 0.210 |
Why?
|
Hemodynamics | 2 | 2019 | 4184 | 0.210 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 2 | 2014 | 207 | 0.210 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1217 | 0.210 |
Why?
|
Boston | 5 | 2014 | 9338 | 0.210 |
Why?
|
Rotation | 2 | 2016 | 513 | 0.200 |
Why?
|
Hospital Mortality | 2 | 2016 | 5343 | 0.200 |
Why?
|
Patient Readmission | 3 | 2023 | 3286 | 0.200 |
Why?
|
Predictive Value of Tests | 11 | 2021 | 15398 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.200 |
Why?
|
Galectin 3 | 2 | 2015 | 238 | 0.200 |
Why?
|
Outpatients | 5 | 2021 | 1595 | 0.190 |
Why?
|
Patient Care Team | 1 | 2013 | 2517 | 0.190 |
Why?
|
Clinical Competence | 3 | 2017 | 4863 | 0.190 |
Why?
|
Gastroplasty | 1 | 2003 | 153 | 0.190 |
Why?
|
Diastole | 4 | 2017 | 785 | 0.180 |
Why?
|
Research Design | 1 | 2017 | 6209 | 0.180 |
Why?
|
Prognosis | 13 | 2024 | 29922 | 0.180 |
Why?
|
Young Adult | 21 | 2021 | 59889 | 0.180 |
Why?
|
Hospitals | 2 | 2023 | 3888 | 0.170 |
Why?
|
Troponin I | 2 | 2015 | 655 | 0.170 |
Why?
|
Radiology | 1 | 2014 | 2090 | 0.170 |
Why?
|
Time Factors | 17 | 2020 | 40065 | 0.170 |
Why?
|
Middle Aged | 40 | 2022 | 223009 | 0.160 |
Why?
|
Pulmonary Gas Exchange | 2 | 2019 | 389 | 0.160 |
Why?
|
Soccer | 1 | 2021 | 137 | 0.160 |
Why?
|
Societies, Medical | 1 | 2011 | 3956 | 0.160 |
Why?
|
Coronary Occlusion | 1 | 2021 | 283 | 0.150 |
Why?
|
Cardiac Output | 2 | 2019 | 840 | 0.150 |
Why?
|
Swimming | 1 | 2019 | 212 | 0.150 |
Why?
|
Obesity, Morbid | 2 | 2013 | 1292 | 0.150 |
Why?
|
Atrial Appendage | 1 | 2021 | 284 | 0.140 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 3356 | 0.140 |
Why?
|
Ultrasonography | 6 | 2012 | 5993 | 0.140 |
Why?
|
Aged | 27 | 2023 | 171117 | 0.140 |
Why?
|
Ventricular Function, Right | 5 | 2016 | 629 | 0.140 |
Why?
|
Performance-Enhancing Substances | 1 | 2017 | 31 | 0.140 |
Why?
|
Coronary Vessels | 3 | 2018 | 3096 | 0.130 |
Why?
|
Adult | 32 | 2022 | 223044 | 0.130 |
Why?
|
Follow-Up Studies | 13 | 2020 | 39193 | 0.130 |
Why?
|
Pressure | 1 | 2019 | 1168 | 0.130 |
Why?
|
Medicare | 2 | 2018 | 6823 | 0.130 |
Why?
|
Norepinephrine | 1 | 2019 | 900 | 0.130 |
Why?
|
Bundle-Branch Block | 2 | 2011 | 280 | 0.120 |
Why?
|
Heart Failure, Systolic | 1 | 2017 | 135 | 0.120 |
Why?
|
Endothelin-1 | 1 | 2017 | 295 | 0.120 |
Why?
|
Cardiomyopathies | 2 | 2022 | 2067 | 0.120 |
Why?
|
Epinephrine | 1 | 2019 | 783 | 0.120 |
Why?
|
Hypotension, Orthostatic | 1 | 2018 | 257 | 0.120 |
Why?
|
Systole | 5 | 2017 | 935 | 0.120 |
Why?
|
General Practitioners | 1 | 2016 | 105 | 0.120 |
Why?
|
Liability, Legal | 1 | 2016 | 209 | 0.120 |
Why?
|
Hypertension | 5 | 2019 | 8626 | 0.120 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3413 | 0.120 |
Why?
|
Naval Medicine | 1 | 2014 | 30 | 0.120 |
Why?
|
Amyloidosis | 1 | 2022 | 885 | 0.120 |
Why?
|
Massachusetts | 3 | 2016 | 8875 | 0.120 |
Why?
|
Beneficence | 1 | 1994 | 56 | 0.120 |
Why?
|
Ethics | 1 | 1994 | 93 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2020 | 729 | 0.110 |
Why?
|
Societies | 1 | 1994 | 106 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2023 | 81514 | 0.110 |
Why?
|
Moral Obligations | 1 | 1994 | 91 | 0.110 |
Why?
|
Diagnosis, Differential | 4 | 2018 | 12976 | 0.110 |
Why?
|
Heart Failure, Diastolic | 1 | 2014 | 77 | 0.110 |
Why?
|
Hypopituitarism | 1 | 2015 | 254 | 0.110 |
Why?
|
Feedback | 2 | 2017 | 796 | 0.110 |
Why?
|
Lanthanum | 1 | 2013 | 30 | 0.110 |
Why?
|
Myocardium | 2 | 2017 | 4760 | 0.110 |
Why?
|
Phosphorus, Dietary | 1 | 2013 | 20 | 0.110 |
Why?
|
Chest Pain | 2 | 2018 | 1100 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2023 | 59489 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 2 | 2014 | 2247 | 0.100 |
Why?
|
Risk Factors | 13 | 2017 | 74840 | 0.100 |
Why?
|
Pyrazoles | 1 | 2023 | 2033 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6499 | 0.100 |
Why?
|
Blood Pressure Determination | 2 | 2014 | 647 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2020 | 1030 | 0.100 |
Why?
|
Preventive Health Services | 1 | 2017 | 570 | 0.100 |
Why?
|
Acromegaly | 1 | 2015 | 316 | 0.100 |
Why?
|
Altruism | 1 | 1994 | 211 | 0.100 |
Why?
|
Aorta | 2 | 2020 | 2028 | 0.100 |
Why?
|
Cardiac Volume | 2 | 2010 | 196 | 0.100 |
Why?
|
United States | 13 | 2021 | 72903 | 0.100 |
Why?
|
Tendon Injuries | 1 | 2015 | 329 | 0.100 |
Why?
|
Social Responsibility | 1 | 1994 | 382 | 0.090 |
Why?
|
False Positive Reactions | 2 | 2011 | 955 | 0.090 |
Why?
|
Laparoscopy | 1 | 2003 | 2039 | 0.090 |
Why?
|
Chelating Agents | 1 | 2013 | 380 | 0.090 |
Why?
|
Adolescent | 14 | 2021 | 88835 | 0.090 |
Why?
|
National Health Programs | 1 | 1994 | 443 | 0.090 |
Why?
|
Torsion, Mechanical | 1 | 2010 | 15 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20124 | 0.090 |
Why?
|
Equipment Safety | 1 | 2012 | 250 | 0.090 |
Why?
|
Human Growth Hormone | 1 | 2015 | 638 | 0.090 |
Why?
|
Torque | 1 | 2011 | 132 | 0.090 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2010 | 68 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 753 | 0.080 |
Why?
|
Learning Curve | 1 | 2012 | 232 | 0.080 |
Why?
|
Purines | 2 | 2023 | 615 | 0.080 |
Why?
|
Reminder Systems | 1 | 2013 | 388 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2015 | 4058 | 0.080 |
Why?
|
Phosphates | 1 | 2013 | 763 | 0.080 |
Why?
|
Cross-Sectional Studies | 11 | 2021 | 26318 | 0.080 |
Why?
|
Treatment Outcome | 13 | 2019 | 65188 | 0.080 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2011 | 262 | 0.080 |
Why?
|
Troponin T | 1 | 2014 | 785 | 0.080 |
Why?
|
Disease Progression | 6 | 2015 | 13632 | 0.080 |
Why?
|
Algorithms | 2 | 2020 | 14071 | 0.080 |
Why?
|
Hypogonadism | 1 | 2015 | 801 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1944 | 0.080 |
Why?
|
Gastrectomy | 1 | 2013 | 694 | 0.080 |
Why?
|
Physicians | 2 | 2017 | 4588 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2015 | 1094 | 0.070 |
Why?
|
Alcohol-Induced Disorders | 1 | 2008 | 27 | 0.070 |
Why?
|
Resistance Training | 1 | 2010 | 196 | 0.070 |
Why?
|
Renal Artery | 1 | 2009 | 345 | 0.070 |
Why?
|
Universities | 1 | 2013 | 998 | 0.070 |
Why?
|
Weight Loss | 2 | 2013 | 2710 | 0.070 |
Why?
|
Thrombosis | 1 | 2021 | 2949 | 0.070 |
Why?
|
Pulmonary Artery | 1 | 2016 | 1935 | 0.070 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 871 | 0.070 |
Why?
|
Aortic Valve Insufficiency | 1 | 2011 | 575 | 0.070 |
Why?
|
Community Health Services | 1 | 2012 | 657 | 0.070 |
Why?
|
Germany | 2 | 2013 | 882 | 0.070 |
Why?
|
Incidence | 4 | 2016 | 21480 | 0.070 |
Why?
|
Ventricular Fibrillation | 1 | 2009 | 533 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2892 | 0.070 |
Why?
|
Hemangiosarcoma | 1 | 1989 | 211 | 0.070 |
Why?
|
Reference Values | 2 | 2011 | 4908 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1657 | 0.070 |
Why?
|
Health Services for the Aged | 1 | 2009 | 265 | 0.070 |
Why?
|
Critical Care | 1 | 2019 | 2712 | 0.060 |
Why?
|
Chronic Disease | 6 | 2019 | 9347 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2229 | 0.060 |
Why?
|
Health Care Reform | 1 | 1994 | 1259 | 0.060 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1604 | 0.060 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2184 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2013 | 820 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3685 | 0.060 |
Why?
|
Pediatrics | 2 | 2017 | 3606 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2418 | 0.060 |
Why?
|
Odds Ratio | 5 | 2015 | 9649 | 0.060 |
Why?
|
Europe | 1 | 2011 | 3423 | 0.060 |
Why?
|
Angiography | 1 | 2009 | 1581 | 0.060 |
Why?
|
Observer Variation | 1 | 2010 | 2615 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1456 | 0.050 |
Why?
|
Vectorcardiography | 1 | 1983 | 48 | 0.050 |
Why?
|
Equipment Design | 1 | 2012 | 3481 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3105 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2014 | 2128 | 0.050 |
Why?
|
Pandemics | 2 | 2021 | 8703 | 0.050 |
Why?
|
Substance-Related Disorders | 2 | 2017 | 4416 | 0.050 |
Why?
|
Quality Control | 2 | 2016 | 837 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4873 | 0.050 |
Why?
|
Quality of Life | 2 | 2011 | 13462 | 0.050 |
Why?
|
Heart Defects, Congenital | 2 | 2017 | 4697 | 0.050 |
Why?
|
Organ Transplantation | 1 | 2013 | 1174 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Registries | 4 | 2022 | 8297 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1727 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6203 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8733 | 0.050 |
Why?
|
Pulse | 1 | 2021 | 215 | 0.050 |
Why?
|
Inpatients | 1 | 2013 | 2564 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2009 | 1531 | 0.050 |
Why?
|
Pregnancy | 1 | 2003 | 30260 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3672 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2011 | 1566 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2003 | 15747 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2012 | 5302 | 0.040 |
Why?
|
Tachycardia, Ventricular | 1 | 2009 | 1310 | 0.040 |
Why?
|
Delivery of Health Care | 2 | 2017 | 5370 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2017 | 22223 | 0.040 |
Why?
|
Gorilla gorilla | 1 | 2019 | 29 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 15842 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3251 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2019 | 224 | 0.040 |
Why?
|
Diuretics | 2 | 2013 | 613 | 0.040 |
Why?
|
Severity of Illness Index | 5 | 2016 | 15880 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2019 | 187 | 0.040 |
Why?
|
Fibrin | 1 | 2021 | 513 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2310 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7875 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 1145 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12509 | 0.030 |
Why?
|
Logistic Models | 1 | 2012 | 13266 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12056 | 0.030 |
Why?
|
Medical History Taking | 2 | 2010 | 777 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2017 | 415 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 2009 | 11499 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 1514 | 0.030 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2016 | 103 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3785 | 0.030 |
Why?
|
Pennsylvania | 1 | 2016 | 614 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2406 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10383 | 0.030 |
Why?
|
Coronary Angiography | 3 | 2017 | 4493 | 0.030 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2033 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2017 | 607 | 0.030 |
Why?
|
American Medical Association | 1 | 1994 | 60 | 0.030 |
Why?
|
Ships | 1 | 2014 | 53 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1013 | 0.030 |
Why?
|
Rupture | 1 | 2015 | 443 | 0.030 |
Why?
|
Economics | 1 | 1994 | 141 | 0.030 |
Why?
|
Aortic Valve | 2 | 2020 | 1968 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 1989 | 3181 | 0.030 |
Why?
|
Immunoassay | 1 | 2017 | 741 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2018 | 532 | 0.030 |
Why?
|
Atrial Function, Left | 1 | 2015 | 189 | 0.030 |
Why?
|
Splenic Neoplasms | 1 | 1994 | 97 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5876 | 0.030 |
Why?
|
Professional Autonomy | 1 | 1994 | 172 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2021 | 6547 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 8067 | 0.030 |
Why?
|
Health Planning | 1 | 1994 | 233 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20659 | 0.030 |
Why?
|
Medical Records | 1 | 2018 | 1409 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2013 | 368 | 0.020 |
Why?
|
Organizational Policy | 1 | 1994 | 434 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 1989 | 4274 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2016 | 988 | 0.020 |
Why?
|
Florida | 1 | 2013 | 416 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1915 | 0.020 |
Why?
|
Lisinopril | 1 | 2011 | 60 | 0.020 |
Why?
|
Atrial Function, Right | 1 | 2011 | 32 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36532 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2016 | 978 | 0.020 |
Why?
|
Furosemide | 1 | 2011 | 175 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1617 | 0.020 |
Why?
|
Galectins | 1 | 2013 | 294 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2119 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2910 | 0.020 |
Why?
|
Social Justice | 1 | 1994 | 485 | 0.020 |
Why?
|
Heart Septum | 1 | 2011 | 303 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1187 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16721 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2424 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14652 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3432 | 0.020 |
Why?
|
Protein Precursors | 1 | 2012 | 1134 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2018 | 1221 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2011 | 589 | 0.020 |
Why?
|
Age Factors | 3 | 2015 | 18380 | 0.020 |
Why?
|
Blood Proteins | 1 | 2013 | 1188 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2411 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2013 | 1237 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2015 | 2739 | 0.020 |
Why?
|
Standard of Care | 1 | 2011 | 567 | 0.020 |
Why?
|
Lymphocytes | 1 | 1994 | 2599 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2352 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9591 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1529 | 0.020 |
Why?
|
Cohort Studies | 3 | 2015 | 41649 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2927 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2019 | 3800 | 0.020 |
Why?
|
Body Mass Index | 1 | 2003 | 13039 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2009 | 413 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2009 | 494 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2475 | 0.010 |
Why?
|
Heart Atria | 1 | 2011 | 1363 | 0.010 |
Why?
|
Lymphoma | 1 | 1994 | 1897 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2844 | 0.010 |
Why?
|
Child | 3 | 2017 | 80564 | 0.010 |
Why?
|
Testosterone | 1 | 2015 | 2494 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2643 | 0.010 |
Why?
|
Curriculum | 1 | 2017 | 3782 | 0.010 |
Why?
|
Software | 1 | 2018 | 4462 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1266 | 0.010 |
Why?
|
Lipids | 1 | 2015 | 3315 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3615 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2009 | 704 | 0.010 |
Why?
|
Sex Factors | 2 | 2015 | 10603 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12437 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8529 | 0.010 |
Why?
|
Body Weight | 2 | 2008 | 4622 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 1490 | 0.010 |
Why?
|
Biopsy | 1 | 2011 | 6763 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 4958 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10563 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12795 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10729 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2009 | 1946 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1980 | 623 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 42500 | 0.010 |
Why?
|
Coronary Disease | 1 | 1988 | 5912 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8731 | 0.010 |
Why?
|
Splenomegaly | 1 | 1994 | 192 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1994 | 696 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1980 | 1466 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1994 | 2548 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1994 | 1602 | 0.010 |
Why?
|
Cytoplasm | 1 | 1994 | 1500 | 0.000 |
Why?
|
Fatal Outcome | 1 | 1994 | 1831 | 0.000 |
Why?
|
Immunophenotyping | 1 | 1994 | 1866 | 0.000 |
Why?
|
Diatrizoate | 1 | 1988 | 81 | 0.000 |
Why?
|
Diatrizoate Meglumine | 1 | 1988 | 80 | 0.000 |
Why?
|
Spleen | 1 | 1994 | 2296 | 0.000 |
Why?
|
Animals | 1 | 2019 | 168764 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1994 | 2867 | 0.000 |
Why?
|
Parenteral Nutrition, Total | 1 | 1985 | 304 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1994 | 5881 | 0.000 |
Why?
|
Drug Combinations | 1 | 1988 | 2077 | 0.000 |
Why?
|
Random Allocation | 1 | 1985 | 2395 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1985 | 13451 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1994 | 11022 | 0.000 |
Why?
|
Polyethylene Terephthalates | 1 | 1980 | 109 | 0.000 |
Why?
|
Dietary Proteins | 1 | 1985 | 959 | 0.000 |
Why?
|
Heart Arrest, Induced | 1 | 1980 | 358 | 0.000 |
Why?
|
Eating | 1 | 1985 | 1540 | 0.000 |
Why?
|
Blood Vessel Prosthesis | 1 | 1980 | 912 | 0.000 |
Why?
|
Contrast Media | 1 | 1988 | 5329 | 0.000 |
Why?
|
Radiography | 1 | 1980 | 6919 | 0.000 |
Why?
|